| First Author | Koutcher JA | Year | 2002 |
| Journal | Neoplasia | Volume | 4 |
| Issue | 6 | Pages | 480-5 |
| PubMed ID | 12407441 | Mgi Jnum | J:79700 |
| Mgi Id | MGI:2388794 | Doi | 10.1038/sj.neo.7900269 |
| Citation | Koutcher JA, et al. (2002) MRI of mouse models for gliomas shows similarities to humans and can be used to identify mice for preclinical trials. Neoplasia 4(6):480-5 |
| abstractText | Magnetic resonance imaging (MRI) has been utilized for screening and detecting brain tumors in mice based upon their imaging characteristics appearance and their pattern of enhancement. Imaging of these tumors reveals many similarities to those observed in humans with identical pathology. Specifically, high-grade murine gliomas have histologic characteristics of glioblastoma multiforme (GBM) with contrast enhancement after intravenous administration of gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA), implying disruption of the blood-brain barrier in these tumors. In contrast, low-grade murine oligodendrogliomas do not reveal contrast enhancement, similar to human tumors. MRI can be used to identify mice with brain neoplasms as inclusion criteria in preclinical trials. |
